Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PHOTOSOUND TECHNOLOGIES, INC.
- Proposal award date
- 2017-09-15
- Contract end date
- 2019-09-16
- UEI
- EHS5G1FNK5A8
- Solicitation number
- PAR15-186
- Topic code
- 100
Research abstract
SUMMARY
PhotoSound Technologies Inc proposes to develop a novel imaging modality for characterization and pre
clinical research of murine models The technology will be capable of three dimensional functional and
molecular imaging of fluorescent labels and reporter genes mapped with high fidelity over robust anatomical
structures such as skin central and peripheral vasculature and internal organs The developed instrument
could be used in broad spectrum of pre clinical research including cancer toxicology tissue engineering and
regeneration cardiovascular and developmental biology
Optical in vivo imaging methods fluorescence and bioluminescence found great popularity among
researchers as affordable convenient and very sensitive molecular imaging tools for pre clinical studies and
development of animal models However their stand alone application is impeded by poor spatial resolution
and limitations imposed by two dimensionality of the images A high resolution in vivo D imaging method
which could be easily integrated with optical imaging in a single instrument would have a great impact on the
entire field of small animal research
Photoacoustic tomography is an emerging biomedical imaging modality that has all those requirements
m resolution of D whole body images Ability to use the same instrumentation for excitation of
fluorescence and generation of photoacoustic effect D scans in less than minute However its in vivo
sensitivity to detection of fluorophores is inferior as compared to regular fluorescence techniques Our proposal
is based on pioneering co registered integration of fluorescence and photoacoustic modalities in a single
compact D configuration PAFT D defeating shortcomings of each individual technology
The Phase I project is organized in three specific aims assessing feasibility of Technological
implementation for co registered D photoacoustic tomography and fluorescence in a single compact
instrument for imaging live anesthetized mice Imaging fluorophores and anatomical structures of mice with
resolution exceeding that of established fluorescence imaging Providing imaging information valuable for
development and characterization of pre clinical animal models with case study focused on murine models of
metastatic breast cancer
Phase II will be focused on development and in vivo validation of a commercial instrument with sensitivity and
imaging procedures optimized for various areas of animal model development and preclinical research
Ultimate commercial system will enable in vivo visualization and analysis of native hemoglobin fluorophores
nanoparticles and other photosensitive constructs used for tracking mapping and longitudinal studies The
value proposition of the PAFT D will be built not only around uniqueness and technological superiority of the
product but also by making it affordable for a broad population of research groups and centers Well established cheap and convenient rodent models of human disease currently represent the golden
standard and the first step of in vivo pre clinical studies Development and characterization of such models
requires non invasive functional and molecular imaging techniques which currently have significant
deficiencies in spatial resolution two dimensionality of the images and lack of convenient and cheap
instrumentation providing co registered anatomical referencing This project proposes development of a
compact D imaging solution integrating molecular functional and anatomical imaging with unparallel
combination of sensitivity and resolution which could be employed in broad spectrum of pre clinical research
areas including cancer toxicology tissue engineering and regeneration cardiovascular and developmental
medicine and biology
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
3 SBIR/STTR records share this UEI (2017–2022). Reported award amounts total $2,469,827. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards